Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Cancer Therapy Market Growth From $232.46 Billion In 2026 To $342.09 Billion By 2030 At A CAGR Of 10.1%
The cancer therapy market has experienced rapid expansion in recent years. It is anticipated to increase from $210.44 billion in 2025 to $232.47 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.5%. The growth observed in previous periods is primarily due to rising cancer incidence, the adoption of chemotherapy, improved hospital oncology infrastructure, the expansion of radiation therapy, and an aging population.
The cancer therapy market is projected to experience substantial expansion in the coming years, reaching a valuation of $342.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.1%. This anticipated growth during the forecast period is driven by factors such as biomarker-driven therapies, advancements in the immuno-oncology pipeline, the increasing adoption of precision medicine, rising healthcare expenditure, and improved early cancer detection methods. Key developments expected during this period include the accelerated uptake of immunotherapy, the proliferation of targeted cancer treatments, the broadening scope of precision oncology, a greater reliance on combination therapies, and a pivot towards individualized treatment plans.
Get A Free Sample Report With In-Depth Market Insights:
Cancer Therapy Market Growth Drivers: What’s Behind The Acceleration?
The increasing prevalence of cancer is projected to fuel the expansion of the cancer therapy market. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The rise in cancer cases is primarily attributed to heightened exposure to environmental carcinogens like pollution and tobacco smoke. Cancer therapy plays a crucial role in managing the increasing prevalence of cancer by treating existing conditions, enhancing survival rates, and slowing disease progression. For instance, in February 2024, the World Health Organization (WHO), an intergovernmental organization based in Switzerland, reported that global cancer incidence is anticipated to reach over 35 million new cases by 2050, signifying a 77% increase from the estimated 20 million cases recorded in 2022. Therefore, the growing prevalence of cancer acts as a key driver for the cancer therapy market.
Cancer Therapy Market Segment Analysis Spotlighting Growth Areas
The cancer therapy market covered in this report is segmented –
1) By Therapy Type: Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, Other Therapy Types
2) By Cancer Type: Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynaecologic Cancer, Respiratory Or Lung Cancer, Other Cancer Types
3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers
Subsegments:
1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Other Chemotherapy Drugs
2) By Targeted Therapy: Monoclonal Antibodies, Tyrosine Kinase Inhibitors (TKIs), mTOR Inhibitors, Proteasome Inhibitors, PARP Inhibitors, Other Targeted Agents
3) By Immunotherapy: Immune Checkpoint Inhibitors, CAR T-cell Therapy, Cancer Vaccines, Cytokines, Oncolytic Virus Therapy, Other Immunotherapies
4) By Radiotherapy: External Beam Radiation Therapy (EBRT), Internal Radiation Therapy (Brachytherapy), Systemic Radiation Therapy, Stereotactic Radiosurgery (SRS), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT)
5) By Other Therapy Types: Hormone Therapy, Stem Cell Transplant, Photodynamic Therapy, Cryoablation, Hyperthermia Therapy
Cancer Therapy Market Trends: What’s Defining The Industry’s Next Phase?
Major companies operating in the cancer therapy market are increasingly focusing on developing innovative therapies, such as immuno-oncology drugs, to enhance treatment effectiveness by leveraging the body’s immune system to target and destroy cancer cells. Immuno-oncology drugs constitute a class of cancer treatments designed to stimulate or boost the body’s own immune system to more effectively recognize and attack cancer cells. For instance, in December 2024, Dr. Reddy’s Laboratories Ltd., an India-based pharmaceutical company, introduced Toripalimab in India, marking it as the first and only immuno-oncology medication authorized for the treatment of nasopharyngeal cancer. This launch provides a new, targeted treatment option for patients suffering from this rare and aggressive cancer, with the potential to improve outcomes through advanced immune system engagement. The availability of toripalimab in India underscores Dr. Reddy’s commitment to expanding access to cutting-edge cancer therapies in underserved areas.
Cancer Therapy Market Leading Companies: Who Holds The Strongest Market Presence?
Major companies operating in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., Aptadel Therapeutics S.L.
View The Full Cancer Therapy Market Report:
Cancer Therapy Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the cancer therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model